HK Stock MarketDetailed Quotes
02633 JACOBSON PHARMA
- 0.570
- 0.0000.00%
Market Closed Apr 25 16:09 CST
1.14BMarket Cap4.25P/E (TTM)
0.570High0.560Low148.00KVolume0.560Open0.570Pre Close83.82KTurnover0.01%Turnover Ratio4.52P/E (Static)2.00BShares1.03152wk High0.50P/B1.14BFloat Cap0.54052wk Low0.32Dividend TTM2.00BShs Float1.999Historical High0.318Dividend LFY1.75%Amplitude0.331Historical Low0.566Avg Price2000Lot Size55.26%Div YieldTTM55.79%Div Yield LFY
JACOBSON PHARMA Key Stats
All
YOY
| (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | (Q6)Sep 30, 2020 | (FY)Mar 31, 2020 | (Q6)Sep 30, 2019 | (FY)Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 46.80%339.76M | ---- | 4.93%231.43M | ---- | -16.95%220.55M | ---- | -15.72%265.57M | ---- | 25.42%315.09M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -860.67%-18.15M | ---- | 9.53%-1.89M | ---- | 63.78%-2.09M | ---- | -21.48%-5.76M | ---- | -20.22%-4.75M |
| Dividend (income)- adjustment | ---- | ---- | ---- | ---1.13M | ---- | ---- | ---- | ---- | ---- | ---- |
| Attributable subsidiary (profit) loss | ---- | -5.52%3.56M | ---- | -31.83%3.77M | ---- | 980.10%5.53M | ---- | 86.69%-628K | ---- | ---4.72M |
| Impairment and provisions: | --0 | --0 | --0 | --2.5M | --0 | --0 | --0 | --2.6M | --0 | --0 |
| -Impairment of trade receivables (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --2.6M | ---- | ---- |
| -Other impairments and provisions | ---- | ---- | ---- | --2.5M | ---- | ---- | ---- | ---- | ---- | ---- |
| Revaluation surplus: | --0 | --0 | --0 | -1,542.04%-8.05M | --0 | 59.17%-490K | --0 | 94.94%-1.2M | --0 | -77.57%-23.73M |
| -Fair value of investment properties (increase) | ---- | ---- | ---- | -1,542.04%-8.05M | ---- | 59.17%-490K | ---- | 94.87%-1.2M | ---- | -84.86%-23.37M |
| -Other fair value changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 50.84%-353K |
| Asset sale loss (gain): | --0 | -50.39%-5.35M | --0 | 58.26%-3.56M | --0 | -2,494.38%-8.52M | --0 | 107.05%356K | --0 | -16,730.00%-5.05M |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---10.57M | ---- | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 306.55%1.42M | ---- | -197.86%-687K | ---- | 97.19%702K | ---- | 107.05%356K | ---- | -16,730.00%-5.05M |
| -Loss (gain) from selling other assets | ---- | -135.81%-6.77M | ---- | -313.14%-2.87M | ---- | --1.35M | ---- | ---- | ---- | ---- |
| Depreciation and amortization: | --0 | -4.22%184.46M | --0 | 0.47%192.6M | --0 | 12.25%191.7M | --0 | 47.33%170.78M | --0 | 3.10%115.92M |
| -Depreciation | ---- | -4.22%184.46M | ---- | 0.47%192.6M | ---- | 12.25%191.7M | ---- | 47.33%170.78M | ---- | 3.10%115.92M |
| Financial expense | ---- | 162.56%67.45M | ---- | -14.79%25.69M | ---- | -45.76%30.14M | ---- | -16.05%55.58M | ---- | 43.89%66.2M |
| Special items | ---- | --19.14M | ---- | ---- | ---- | ---- | ---- | -225.52%-6.71M | ---- | -45.05%5.35M |
| Operating profit before the change of operating capital | --0 | 33.87%590.86M | --0 | 1.04%441.36M | --0 | -9.10%436.82M | --0 | 3.50%480.57M | --0 | 15.48%464.31M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -228.40%-53.45M | ---- | 98.86%41.63M | ---- | 140.46%20.93M | ---- | -195.50%-51.74M | ---- | 55.04%-17.51M |
| Accounts receivable (increase)decrease | ---- | 137.87%23.78M | ---- | -61.74%-62.79M | ---- | -1,941,150.00%-38.82M | ---- | 100.01%2K | ---- | 57.46%-21.67M |
| Accounts payable increase (decrease) | ---- | 462.31%116.5M | ---- | 17.21%20.72M | ---- | 4,620.72%17.68M | ---- | -105.79%-391K | ---- | 151.27%6.76M |
| Cash from business operations | -8.46%287.27M | 53.70%677.69M | -1.46%313.8M | 0.99%440.92M | 36.71%318.44M | 1.91%436.61M | -9.31%232.94M | -0.80%428.45M | 22.93%256.86M | 44.44%431.89M |
| Other taxs | -88.03%-10.93M | -40.09%-47.6M | 16.21%-5.82M | -24.21%-33.98M | -198.11%-6.94M | 59.22%-27.35M | -755.77%-2.33M | -85.37%-67.08M | 46.09%355K | 35.39%-36.19M |
| Net cash from operations | -10.28%276.34M | 54.84%630.09M | -1.13%307.99M | -0.57%406.94M | 35.08%311.5M | 13.25%409.26M | -10.34%230.61M | -8.68%361.37M | 22.96%257.21M | 62.85%395.71M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | 398.42%16.42M | 977.61%18.15M | 273.89%3.29M | -19.35%1.68M | --881K | -63.78%2.09M | ---- | 21.48%5.76M | ---- | 20.22%4.75M |
| Dividend received - investment | --1.7M | ---- | ---- | --1.13M | ---- | ---- | ---- | --8.46M | --8.46M | ---- |
| Decrease in deposits (increase) | --100M | ---100M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Sale of fixed assets | 465.00%113K | 536.59%522K | --20K | -74.45%82K | ---- | -63.23%321K | -66.24%262K | -88.96%873K | 39.57%776K | 263.18%7.91M |
| Purchase of fixed assets | -361.60%-64.04M | 1.35%-63M | 63.73%-13.87M | -0.81%-63.86M | 0.25%-38.25M | 24.94%-63.35M | 14.24%-38.35M | -91.51%-84.41M | 73.36%-44.72M | 49.25%-44.07M |
| Sale of subsidiaries | --9.12M | ---- | ---- | ---- | ---- | --40.6M | --39.25M | ---- | ---- | ---- |
| Acquisition of subsidiaries | ---- | --1.86M | ---- | ---- | ---- | -122.57%-240.66M | -38.76%-150.03M | 80.91%-108.12M | 21.35%-108.12M | -1,352.56%-566.38M |
| Recovery of cash from investments | --6.89M | -86.40%10M | ---- | 44.18%73.55M | 849.62%72.99M | --51.01M | --7.69M | ---- | ---- | ---- |
| Cash on investment | ---- | 95.96%-2.51M | 94.93%-908K | 56.97%-62.01M | 83.01%-17.91M | 44.63%-144.11M | -99.52%-105.45M | -528.67%-260.28M | -264.48%-52.85M | 78.89%-41.4M |
| Other items in the investment business | ---- | ---- | ---- | 97.35%-510K | ---- | -10,374.33%-19.21M | 21.39%1.21M | -98.49%187K | -21.26%996K | 198.52%12.42M |
| Net cash from investment operations | 712.24%70.21M | -170.30%-134.98M | -164.77%-11.47M | 86.62%-49.94M | 107.21%17.71M | 14.68%-373.31M | -25.56%-245.42M | 30.20%-437.53M | 38.53%-195.46M | -90.86%-626.79M |
| Net cash before financing | 16.87%346.54M | 38.68%495.11M | -9.93%296.52M | 893.20%357M | 2,323.31%329.21M | 147.20%35.95M | -123.98%-14.81M | 67.04%-76.16M | 156.75%61.75M | -170.57%-231.08M |
| Cash flow from financing activities | ||||||||||
| New borrowing | -97.71%32M | 61.32%1.56B | 211.11%1.4B | -20.12%967M | 13.64%450M | 0.71%1.21B | -60.48%396M | 69.53%1.2B | 254.39%1B | 7.77%709.02M |
| Refund | 86.07%-173M | -11.90%-1.35B | -81.15%-1.24B | -1.47%-1.2B | -83.56%-685.41M | -148.12%-1.19B | -5.62%-373.4M | 38.97%-478.01M | 3.86%-353.53M | -13.26%-783.24M |
| Issuing shares | ---- | ---- | ---- | ---- | ---- | --150.62M | ---- | ---- | ---- | -17.60%412M |
| Interest paid - financing | 3.63%-771K | -7.17%-1.59M | -3.90%-800K | 27.18%-1.48M | 30.51%-770K | 27.15%-2.03M | 14.44%-1.11M | -5,831.91%-2.79M | -5,530.43%-1.3M | ---47K |
| Dividends paid - financing | ---56.03M | -102.69%-106.78M | ---- | 21.44%-52.68M | 88.56%-398K | 33.93%-67.06M | 94.23%-3.48M | -13.98%-101.49M | -3.10%-60.27M | -111.41%-89.05M |
| Absorb investment income | ---- | --9.04M | ---- | ---- | ---- | ---- | --97M | ---- | ---- | ---- |
| Issuance expenses and redemption of securities expenses | ---- | ---5.35M | ---3.04M | ---- | ---- | 98.93%-5.37M | ---- | -146,098.83%-500M | ---500M | 96.46%-342K |
| Other items of the financing business | -214.26%-213.42M | -116.00%-145.28M | -92.60%-67.91M | 15.18%-67.26M | 14.67%-35.26M | 68.63%-79.29M | 32.36%-41.32M | -499.84%-252.78M | -159.27%-61.1M | -27.41%-42.14M |
| Net cash from financing operations | -574.85%-411.23M | 89.77%-36.6M | 131.86%86.6M | -1,775.90%-357.89M | -468.92%-271.84M | 116.05%21.36M | 185.40%73.69M | -164.53%-133.07M | -89.45%25.82M | -45.96%206.2M |
| Effect of rate | 49.74%-686K | 8.49%-744K | -112.29%-1.37M | -150.53%-813K | 22.06%-643K | 95.50%1.61M | -203.77%-825K | 140.92%823K | 167.43%795K | -321.72%-2.01M |
| Net Cash | -116.88%-64.68M | 51,967.53%458.51M | 567.89%383.12M | -101.54%-884K | -2.58%57.36M | 127.39%57.3M | -32.76%58.88M | -740.93%-209.22M | -35.54%87.57M | -108.40%-24.88M |
| Begining period cash | 95.64%936.42M | -0.35%478.65M | -0.35%478.65M | 13.98%480.35M | 13.98%480.35M | -33.09%421.44M | -33.09%421.44M | -4.09%629.84M | -4.09%629.84M | 82.59%656.73M |
| Cash at the end | 1.24%871.05M | 95.64%936.42M | 60.20%860.41M | -0.35%478.65M | 12.01%537.07M | 13.98%480.35M | -33.24%479.5M | -33.09%421.44M | -9.25%718.21M | -4.09%629.84M |
| Cash balance analysis | ||||||||||
| Cash and cash equivalent balance | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | KPMG | -- | KPMG | -- | KPMG | -- | KPMG | -- | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
%Chg